Outlook Therapeutics
OTLK
OTLK
12 hedge funds and large institutions have $2.15M invested in Outlook Therapeutics in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
88% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 8
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$284K | |
| 2 | -$91.8K | |
| 3 | -$31.3K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.6K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$18K |